| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $529.0M | $513.0M | $503.0M |
| YoY Revenue Growth % | +3.1% | +2.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.06B | $925.1M | $802.4M |
| Operating Margin % | 200.5% | 180.3% | 159.5% |
| Net Income (GAAP) | $899.0M | $784.0M | $680.0M |
| EBITDA (Normalized) | $1.16B | $1.00B | $820.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.07B | $1.15B | $885.0M |
| Capital Expenditures (CapEx) | $121.0M | $97.0M | $22.6M |
| Free Cash Flow (FCF) | $952.0M | $1.05B | $862.4M |
| FCF Margin % | 180.0% | 204.9% | 171.4% |
| Return on Invested Capital (ROIC %) | 2.5% | 2.2% | 19.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $36.68B | $37.19B | $1.24B |
| Total Stockholders' Equity | $7.18B | $6.12B | $2.55B |